Is Revelation Biosciences REVB stock the best stock to trade now? It has been breaking it’s trend with a 114% change in PPS in 5 days & 34% increase in volume.
Wondering why this stock is taking off, take a look below.
Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇
Now, let’s go over some of the basic information on this stock before we get in the technical analysis to see if it is the best stock.
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Jun 13, 2022
Announced that it has completed enrollment and dosing of its Phase 1b CLEAR clinical study to evaluate safety and efficacy of intranasal REVTx-99b for the treatment of allergic rhinitis.
Is it the best stock? I wouldn’t say the best but I will say based on the news and the chart, it is a solid play to place on your watchlist.
Reminding all the traders out there to leave your emotions at the door and never, ever, try to trade with money you don’t have to lose.
We strive to find breakout stock alerts and deliver them before the market finds out.
I hope you enjoyed this article, if you would like to receive more exclusive content from us 👇 sign up for our newsletter below. 👇